bluebird bio, Inc.
BLUE
$4.95
$0.061.23%
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 262.99% | -34.09% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 262.99% | -34.09% | |||
| Cost of Revenue | 93.44% | -59.30% | |||
| Gross Profit | 1,445.77% | 90.90% | |||
| SG&A Expenses | -19.50% | -18.74% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.41% | -28.49% | |||
| Operating Income | 43.05% | 27.47% | |||
| Income Before Tax | 53.00% | 25.20% | |||
| Income Tax Expenses | 284.48% | -376.19% | |||
| Earnings from Continuing Operations | 52.78% | 25.29% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 52.78% | 25.29% | |||
| EBIT | 43.05% | 27.47% | |||
| EBITDA | 53.65% | 32.15% | |||
| EPS Basic | 52.89% | 25.36% | |||
| Normalized Basic EPS | 50.76% | 28.72% | |||
| EPS Diluted | 52.89% | 25.36% | |||
| Normalized Diluted EPS | 50.76% | 28.72% | |||
| Average Basic Shares Outstanding | 0.24% | 0.09% | |||
| Average Diluted Shares Outstanding | 0.24% | 0.09% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
